| Dr Mark Allen Crain, DO | |
|
7221 Engle Rd Ste 220, Fort Wayne, IN 46804-2233 | |
| (260) 469-8223 | |
| Not Available |
| Full Name | Dr Mark Allen Crain |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 13 Years |
| Location | 7221 Engle Rd Ste 220, Fort Wayne, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326330200 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085B0100X | Radiology - Body Imaging | DO-04835 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lutheran Hospital Of Indiana | Fort wayne, IN | Hospital |
| Memorial Hospital | Logansport, IN | Hospital |
| Marion General Hospital | Marion, IN | Hospital |
| Adams Memorial Hospital | Decatur, IN | Hospital |
| Dupont Hospital Llc | Fort wayne, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Summit Radiology Pc | 0143295410 | 75 |
| X-ray Physicians Of Shelbyville Pc | 2264420215 | 44 |
| Henry County Memorial Hospital | 6002724085 | 112 |
| Decatur County Memorial Hospital | 7315837671 | 66 |
News Archive
NexMed, Inc., a specialty CRO with a pipeline of product candidates based on the NexACT technology, today announced that Health Canada has confirmed acceptance of the Company's CMC response for review. The Screening Acceptance Letter from Health Canada was issued in connection with its New Drug Submission for Vitaros, the Company's topical treatment for erectile dysfunction.
Researchers conducted a prospective randomized controlled clinical trial at Bern University Hospital in Switzerland to compare a laparoscopic procedure with a mini-laparotomy for insertion of a peritoneal catheter during ventriculoperitoneal (VP) shunt surgery. The deciding factor was the rate of shunt malfunction.
University of Manchester researchers funded by Breast Cancer Now have discovered a new explanation as to why women with oestrogen receptor positive (ER+) breast cancer develop resistance to hormone treatment, and a potential new approach to overcome the problem.
A new video-article in JoVE, Journal of Visualized Experiments, details the use of a new laser-activated bio-adhesive polymer. The chitosan-based polymer, SurgiLux, was developed by scientists at the University of New South Wales.
› Verified 4 days ago
| Entity Name | Northern Indiana Magnetic Resonance Center, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447252200 PECOS PAC ID: 6709780802 Enrollment ID: O20031120000842 |
News Archive
NexMed, Inc., a specialty CRO with a pipeline of product candidates based on the NexACT technology, today announced that Health Canada has confirmed acceptance of the Company's CMC response for review. The Screening Acceptance Letter from Health Canada was issued in connection with its New Drug Submission for Vitaros, the Company's topical treatment for erectile dysfunction.
Researchers conducted a prospective randomized controlled clinical trial at Bern University Hospital in Switzerland to compare a laparoscopic procedure with a mini-laparotomy for insertion of a peritoneal catheter during ventriculoperitoneal (VP) shunt surgery. The deciding factor was the rate of shunt malfunction.
University of Manchester researchers funded by Breast Cancer Now have discovered a new explanation as to why women with oestrogen receptor positive (ER+) breast cancer develop resistance to hormone treatment, and a potential new approach to overcome the problem.
A new video-article in JoVE, Journal of Visualized Experiments, details the use of a new laser-activated bio-adhesive polymer. The chitosan-based polymer, SurgiLux, was developed by scientists at the University of New South Wales.
› Verified 4 days ago
| Entity Name | Henry County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891570537 PECOS PAC ID: 6002724085 Enrollment ID: O20031121000221 |
News Archive
NexMed, Inc., a specialty CRO with a pipeline of product candidates based on the NexACT technology, today announced that Health Canada has confirmed acceptance of the Company's CMC response for review. The Screening Acceptance Letter from Health Canada was issued in connection with its New Drug Submission for Vitaros, the Company's topical treatment for erectile dysfunction.
Researchers conducted a prospective randomized controlled clinical trial at Bern University Hospital in Switzerland to compare a laparoscopic procedure with a mini-laparotomy for insertion of a peritoneal catheter during ventriculoperitoneal (VP) shunt surgery. The deciding factor was the rate of shunt malfunction.
University of Manchester researchers funded by Breast Cancer Now have discovered a new explanation as to why women with oestrogen receptor positive (ER+) breast cancer develop resistance to hormone treatment, and a potential new approach to overcome the problem.
A new video-article in JoVE, Journal of Visualized Experiments, details the use of a new laser-activated bio-adhesive polymer. The chitosan-based polymer, SurgiLux, was developed by scientists at the University of New South Wales.
› Verified 4 days ago
| Entity Name | Decatur County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952300477 PECOS PAC ID: 7315837671 Enrollment ID: O20040318001580 |
News Archive
NexMed, Inc., a specialty CRO with a pipeline of product candidates based on the NexACT technology, today announced that Health Canada has confirmed acceptance of the Company's CMC response for review. The Screening Acceptance Letter from Health Canada was issued in connection with its New Drug Submission for Vitaros, the Company's topical treatment for erectile dysfunction.
Researchers conducted a prospective randomized controlled clinical trial at Bern University Hospital in Switzerland to compare a laparoscopic procedure with a mini-laparotomy for insertion of a peritoneal catheter during ventriculoperitoneal (VP) shunt surgery. The deciding factor was the rate of shunt malfunction.
University of Manchester researchers funded by Breast Cancer Now have discovered a new explanation as to why women with oestrogen receptor positive (ER+) breast cancer develop resistance to hormone treatment, and a potential new approach to overcome the problem.
A new video-article in JoVE, Journal of Visualized Experiments, details the use of a new laser-activated bio-adhesive polymer. The chitosan-based polymer, SurgiLux, was developed by scientists at the University of New South Wales.
› Verified 4 days ago
| Entity Name | X-ray Physicians Of Shelbyville Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144351347 PECOS PAC ID: 2264420215 Enrollment ID: O20040506000325 |
News Archive
NexMed, Inc., a specialty CRO with a pipeline of product candidates based on the NexACT technology, today announced that Health Canada has confirmed acceptance of the Company's CMC response for review. The Screening Acceptance Letter from Health Canada was issued in connection with its New Drug Submission for Vitaros, the Company's topical treatment for erectile dysfunction.
Researchers conducted a prospective randomized controlled clinical trial at Bern University Hospital in Switzerland to compare a laparoscopic procedure with a mini-laparotomy for insertion of a peritoneal catheter during ventriculoperitoneal (VP) shunt surgery. The deciding factor was the rate of shunt malfunction.
University of Manchester researchers funded by Breast Cancer Now have discovered a new explanation as to why women with oestrogen receptor positive (ER+) breast cancer develop resistance to hormone treatment, and a potential new approach to overcome the problem.
A new video-article in JoVE, Journal of Visualized Experiments, details the use of a new laser-activated bio-adhesive polymer. The chitosan-based polymer, SurgiLux, was developed by scientists at the University of New South Wales.
› Verified 4 days ago
| Entity Name | Summit Radiology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073584587 PECOS PAC ID: 0143295410 Enrollment ID: O20040831000152 |
News Archive
NexMed, Inc., a specialty CRO with a pipeline of product candidates based on the NexACT technology, today announced that Health Canada has confirmed acceptance of the Company's CMC response for review. The Screening Acceptance Letter from Health Canada was issued in connection with its New Drug Submission for Vitaros, the Company's topical treatment for erectile dysfunction.
Researchers conducted a prospective randomized controlled clinical trial at Bern University Hospital in Switzerland to compare a laparoscopic procedure with a mini-laparotomy for insertion of a peritoneal catheter during ventriculoperitoneal (VP) shunt surgery. The deciding factor was the rate of shunt malfunction.
University of Manchester researchers funded by Breast Cancer Now have discovered a new explanation as to why women with oestrogen receptor positive (ER+) breast cancer develop resistance to hormone treatment, and a potential new approach to overcome the problem.
A new video-article in JoVE, Journal of Visualized Experiments, details the use of a new laser-activated bio-adhesive polymer. The chitosan-based polymer, SurgiLux, was developed by scientists at the University of New South Wales.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Allen Crain, DO 7221 Engle Rd Ste 220, Fort Wayne, IN 46804-2233 Ph: (260) 469-8223 | Dr Mark Allen Crain, DO 7221 Engle Rd Ste 220, Fort Wayne, IN 46804-2233 Ph: (260) 469-8223 |
News Archive
NexMed, Inc., a specialty CRO with a pipeline of product candidates based on the NexACT technology, today announced that Health Canada has confirmed acceptance of the Company's CMC response for review. The Screening Acceptance Letter from Health Canada was issued in connection with its New Drug Submission for Vitaros, the Company's topical treatment for erectile dysfunction.
Researchers conducted a prospective randomized controlled clinical trial at Bern University Hospital in Switzerland to compare a laparoscopic procedure with a mini-laparotomy for insertion of a peritoneal catheter during ventriculoperitoneal (VP) shunt surgery. The deciding factor was the rate of shunt malfunction.
University of Manchester researchers funded by Breast Cancer Now have discovered a new explanation as to why women with oestrogen receptor positive (ER+) breast cancer develop resistance to hormone treatment, and a potential new approach to overcome the problem.
A new video-article in JoVE, Journal of Visualized Experiments, details the use of a new laser-activated bio-adhesive polymer. The chitosan-based polymer, SurgiLux, was developed by scientists at the University of New South Wales.
› Verified 4 days ago
Dr. Benjamin Jon Moreno, MD, PHD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3707 New Vision Dr Ste 110, Fort Wayne, IN 46845 Phone: 260-469-6602 Fax: 260-484-5919 | |
Dr. Andre Byard Stovall, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 5001 Us Highway 30 W Ste D, Fort Wayne, IN 46818 Phone: 260-432-1568 Fax: 260-432-4969 | |
Dr. Christopher Edson Carrel, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3707 New Vision Dr, Fort Wayne, IN 46845 Phone: 604-696-6022 Fax: 616-363-7290 | |
Dr. Gregg R Mattison, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 3707 New Vision Drive, Fort Wayne, IN 46895 Phone: 260-471-9466 Fax: 260-484-5919 | |
Christopher M Wing, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3707 New Vision Dr, Fort Wayne, IN 46845 Phone: 260-471-9466 Fax: 260-484-5919 | |
Dr. Ahdy Messiha, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 7950 W Jefferson Blvd, Fort Wayne, IN 46804 Phone: 260-432-1568 Fax: 260-432-4969 | |
Vivek K. Sharma, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5001 Us Highway 30 W Ste D, Fort Wayne, IN 46818 Phone: 260-432-1568 Fax: 260-432-4969 |